ConceptioArchiveHAL (France)
HAL (France)open access

Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC

Lorenza Rimassa et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
0, 1, 2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 326310
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.